![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2020
Hassler, Signe; Bachelet, Delphine; Duhaze, Julianne; Szely, Natacha; Gleizes, Aude; Abina, Salima Hacein-Bey; Aktas, Orhan; Auer, Michael; Avouac, Jerome; Birchler, Mary; Bouhnik, Yoram; Brocq, Olivier; Buck-Martin, Dorothea; Cadiot, Guillaume; Carbonnel, Franck; Chowers, Yehuda; Comabella, Manuel; Derfuss, Tobias; De Vries, Niek; Donnellan, Naoimh; Doukani, Abiba; Guger, Michael; Hartung, Hans-Peter; Havrdova, Eva Kubala; Hemmer, Bernhard; Huizinga, Tom; Ingenhoven, Kathleen; Hyldgaard-Jensen, Poul Erik; Jury, Elizabeth C.; Khalil, Michael; Kieseier, Bernd; Lauren, Anna; Lindberg, Raija; Loercher, Amy; Maggi, Enrico; Manson, Jessica; Mauri, Claudia; Oumoussa, Badreddine Mohand; Montalban, Xavier; Nachury, Maria; Nytrova, Petra; Richez, Christophe; Ryner, Malin; Sellebjerg, Finn; Sievers, Claudia; Sikkema, Dan; Soubrier, Martin; Tourdot, Sophie; Trang, Caroline; Vultaggio, Alessandra; Warnke, Clemens; Spindeldreher, Sebastian; Donnes, Pierre; Hickling, Timothy P.; Mery, Agnes Hincelin; Allez, Matthieu; Deisenhammer, Florian; Fogdell-Hahn, Anna; Mariette, Xavier; Pallardy, Marc und Broet, Philippe
(2020):
Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium.
In: PLOS Medicine 17(10), e1003348 [PDF, 1MB]
In: PLOS Medicine 17(10), e1003348 [PDF, 1MB]
2016
Bachelet, Delphine; Hässler, Signe; Mbogning, Cyprien; Link, Jenny; Ryner, Malin; Ramanujam, Ryan; Auer, Michael; Jensen, Poul Erik Hyldgaard; Koch-Henriksen, Nils; Warnke, Clemens; Ingenhoven, Kathleen; Buck, Dorothea; Grummel, Verena; Lawton, Andy; Donnellan, Naoimh; Hincelin-Mery, Agnes; Sikkema, Dan; Pallardy, Marc; Kieseier, Bernd; Hemmer, Bernard; Hartung, Hans Peter; Sorensen, Per Soelberg; Deisenhammer, Florian; Dönnes, Pierre; Davidson, Julie; Fogdell-Hahn, Anna und Broet, Philippe
(2016):
Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis.
In: PLOS ONE 11(11), e0162752 [PDF, 2MB]
In: PLOS ONE 11(11), e0162752 [PDF, 2MB]
2011
Tony, Hans-Peter; Burmester, Gerd; Schulze-Koops, Hendrik; Grunke, Mathias; Henes, Joerg; Kötter, Ina; Haas, Judith; Unger, Leonore; Lovric, Svjetlana; Haubitz, Marion; Fischer-Betz, Rebecca; Chehab, Gamal; Rubbert-Roth, Andrea; Specker, Christof; Weinerth, Jutta; Holle, Julia; Müller-Ladner, Ulf; König, Ramona; Fiehn, Christoph; Burgwinkel, Philip; Budde, Klemens; Sörensen, Helmut; Meurer, Michael; Aringer, Martin; Kieseier, Bernd; Erfurt-Berge, Cornelia; Sticherling, Michael; Veelken, Roland; Ziemann, Ulf; Strutz, Frank; Meier, Florian M. P.; Hunzelmann, Nico; Schmidt, Enno; Bergner, Raoul; Schwarting, Andreas; Eming, Rüdiger; Hertl, Michael; Stadler, Rudolf; Schwarz-Eywill, Michael; Wassenberg, Siegfried; Fleck, Martin; Metzler, Claudia; Zettl, Uwe; Westphal, Jens; Heitmann, Stefan; Herzog, Anna L.; Wiendl, Heinz; Jakob, Waltraud; Schmidt, Elvira; Freivogel, Klaus und Dörner, Thomas
(2011):
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID).
In: Arthritis Research & Therapy
13:R75
[PDF, 694kB]